Development of a novel Industrial Air Sanitiser (IAS), to significantly reduce incidence of workers from passing on illnesses (including but not limited to COVID-19) and improve indoor air quality

BPP-Tech拥有超过37年的工程经验，不断为客户提供创新。在COVID-19大流行期间，他们开发了一种空气质量消毒器（AMS），该消毒器具有持续消毒小型室内空气空间的能力，占用率高（如全科医生手术）摧毁SARS-CoV-2和其他病原体以降低感染风险。大多数专家现在同意，SARS-CoV-2（像大多数呼吸道病毒一样）的主要传播是通过空气中的呼吸道飞沫/空气传播的病毒颗粒，特别是在拥挤/通风不良的空间中。AMS现在正处于商业化的边缘，将支持公共卫生干预工作（疫苗接种/屏蔽/追踪），以帮助经济恢复正常，并防止新的病毒株和未来的流行病。该项目将在此基础上开发一种“工业空气消毒剂”（IAS），其目标是更大的空间（如工厂、大型餐厅、电影院、博物馆和室内农场）以达到非常高的病毒杀灭水平，针对SARS-Cov-2以及其他问题病毒（例如禽流感，它会影响禽鸟，并透过动物传染病的变异威胁人类）及其他未知的病毒品种。该系统亦会为非大流行的应用而设计，旨在显著改善室内空气质素（室内空气质量），这是损害人类健康、疾病、过早死亡和工作场所疾病的重要原因。不幸的是，室内空气的污染程度可能是室外空气的2-5倍（由于缺乏稀释），这意味着如果室外的花粉数量或空气污染率很高，室内的情况可能会更糟。开发IAS将需要对AMS系统进行重大而彻底的重新设计，以便它能够达到更大室内空间所需的空气流速。这将涉及广泛的实验室测试，计算流体动力学（CFD）建模，原型建造和重新测试，以确保良好的设计。如果成功，这将为BPP-Tech带来可观的收入，并在东北部（BPP-Tech和整个供应链）创造大量的制造业就业机会，以扩大生产以满足需求。

BPP-Tech brings over 37 years' engineering experience, consistently delivering innovation to its customers.During the COVID-19 pandemic, they developed an Air Mass Sanitiser (AMS) which has the capability to continuously sanitise small indoor air spaces with high-occupancy rates (such as GP surgeries) to destroy SARS-CoV-2 and other pathogens to reduce the risk of infection.Most experts now agree, primary transmission of SARS-CoV-2 (like most respiratory viruses) is through respiratory droplets/airborne viral particles in the air mass, particularly present in crowded/poorly-ventilated spaces. The AMS is now on the brink of commercialisation and will support public-health intervention efforts (vaccination/shielding/track-and-trace) to help the economy return to normal and safeguard against new virus strains and future pandemics.This project will build on this work to develop an 'Industrial-Air-Sanitiser' (IAS), which targets much higher volume spaces (such as factories, large-restaurants, cinemas, museums and indoor farms) to achieve very high-levels of viral kill, targeting both SARS-Cov-2 as well as other problematic viruses (such as avian flu which affects birds and threatens humans through zoonotic mutation) and other unknown virus-strains.The IAS will also be designed for non-pandemic applications aiming to significantly improve Indoor Air Quality (IAQ), which is a significant cause of damage to human health, disease, premature deaths and workplace sickness. Unfortunately, indoor air can be 2-5 times more polluted than outdoor air (due to lack of dilution) meaning if the pollen count or air pollution rate outside is high, it can be significantly worse indoors.Developing the IAS will require significant and radical redesign of the AMS system so it can achieve the requisite air-flow rates for larger indoor spaces. This will involve extensive laboratory testing, computational fluid dynamics (CFD) modelling, prototype building and re-testing to ensure a good design. If successful, this will generate significant revenues for BPP-Tech and lead to significant manufacturing employment (in BPP-Tech and across the supply-chain) in the North East to scale up production to meet demand.